SynthesisThe oncologist2018

Azacitidine in Lower-Risk Myelodysplastic Syndromes: A Meta-Analysis of Data from Prospective Studies.

Rami Komrokji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.